Applied Digital benefits from AI data center demand, a REIT shift, modular sites, hyperscaler deals, and a $1B NOI target.
The session highlights how InfluxDB 3 enables low-latency analytics and how MCP makes real-time data easier to explore. The talk will include a live demo where we will ask questions like “Is the ...
Anthropic’s Labs unit is expanding into a full-fledged incubator, with ambitious plans to double team size within six months. This pivot comes as Anthropic closes a $10 billion funding round at a $350 ...
Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...
China’s fast-growing AI video tool has reached 60 million users, emerging as a serious competitor to OpenAI’s Sora in the ...
It has been around a year since Beam Therapeutics slashed its headcount and R&D programmes to focus mainly on a sickle cell disease candidate – and the biotech has now revealed the first data with the ...
Facebook parent Meta has reached nuclear power deals with three companies as it continues to look for electricity sources for ...
The world tried to kill Andy off but he had to stay alive to to talk about what happened with databases in 2025.
The Ministry of Statistics and Programme Implementation (MoSPI) is in the process of revising the base years for computing Consumer Price Index (CPI), Index of Industrial Production (IIP) and Gross ...
The Ministry of Statistics and Programme Implementation plans to release a new series of economic data with an updated base year for inflation, national accounts, and industrial production. A ...
Steve Kornacki pointed out “worrying” signs for Trump in a new poll as he noticed shifts within the GOP and his formerly “unmovable” MAGA followers. Reporter NBC’s chief data analyst Steve Kornacki ...
Beam Therapeutics recently reported additional safety and efficacy data from its BEACON Phase 1/2 trial of ristoglogene autogetemcel (risto-cel) for sickle cell disease, highlighting efficient ex vivo ...